Science-Speak Goes Oulipo

Jargon, the cognoscenti's verbal equivalent of a secret handshake, is the bane of the science writer (SW). Confronted with the opacity of this linguistic shortcut, the mournful SW has two choices: ignore it or learn it; the former untenable, the latter distasteful, given the risk of becoming part of the problem. Hopefully, every nascent SW opts for the only honorable choice, on the grounds of knowing thine enemy. But the impossibility of really knowing jargon soon reveals itself. Irritatingly

Written bySteve Bunk
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Jargon, the cognoscenti's verbal equivalent of a secret handshake, is the bane of the science writer (SW). Confronted with the opacity of this linguistic shortcut, the mournful SW has two choices: ignore it or learn it; the former untenable, the latter distasteful, given the risk of becoming part of the problem. Hopefully, every nascent SW opts for the only honorable choice, on the grounds of knowing thine enemy. But the impossibility of really knowing jargon soon reveals itself. Irritatingly, this weird lexicon turns out to be an often-legitimate shorthand for layers of meaning, and the outsider can hope to penetrate no further than the conceptual surface.

That realization awakens the problem-solver in the SW, who mutters, "If I can't master the jargon, I'll change it." Tentatively at first, a few acronyms are eliminated and arcane words replaced with plain ones, in the eager expectation that this will contribute to clarity. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies